At the American College of Medical Genetics and Genomics annual meeting in Phoenix, WuXi presented results from a pilot study involving 190 individuals.
Researchers found mutations thought to be associated with embryo development and used them to recreate early cellular life in the human body.
The company also announced that it is launching a new end-to-end clinical sequencing platform.
Based on a recent survey of 40 labs, the investment bank believes that labs will adopt the new NovaSeq instrument faster than previously anticipated.
The clinical genetics and genomics testing firm said the funding will help as it seeks to consolidate its presence in international markets.
Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.
An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.
The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.
In Nature this week: genotypes linked to hip osteoarthritis, and more.
Our roundtable of industry experts will provide an overview of the current regulatory landscape for clinical genomics tests.
In this webinar, Gregory J. Tsongalis of Dartmouth Hitchcock Medical Center will discuss how his lab developed and validated a cancer hotspot assay.
This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.
This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.